![](https://www.worldpharmatoday.com/images/nBanners/Docuvera-728x90.jpeg")
Press Releases
PharmaDiagnostics’ SoPRano (TM) wins prestigious product award at SBS 2011
PharmaDiagnostics NV, a company developing and marketing a broadly-enabling, label-free screening technology that uniquely does not require specialized equipment, announces today that their SoPRano(TM)...
Press Releases
Sun Pharma and Merck Establish Joint Venture to Develop and Commercialize Novel Formulations and Combinations of Medicines
Merck & Co., Inc., a global health care leader, known as MSD outside the United States and Canada,and Sun Pharmaceutical Industries Ltd., (“Sun...
Press Releases
Integromics and Ingenuity expand their co-operation with the integration of a fourth Integromics product to Ingenuity’s IPA
Integromics, a market leader in IT solutions for life sciences in the field of genomics and proteomics, today announces that it has extended its...
Press Releases
AstraZeneca demonstrates commitment to predictive science at international modelling conference
The 2011 American Conference of Pharmacometrics (ACOP) got underway this weekend with attendees from around the world converging on San Diego, US -...
Press Releases
Oncodesign offers world’s most comprehensive collection of patient-derived colorectal tumor models
Oncodesign announced today that the company has acquired exclusive commercialization rights to distribute the world’s most comprehensive collection of human colorectal cancer models directly...
Press Releases
CIT launches LeadScreen (TM), a new range of fast, cost-effective services for drug candidate selection
CIT, a leading European non-clinical CRO specialized in health and safety research, announces today a new range of fast and economical services to meet...
Press Releases
Ken Jones, COO Europe, Astellas joins GSK, Shire, Takeda and Bausch & Lomb on value based selling panel session
With one week to go SFE Europe shows no sign of slowing down. With over 550 confirmed attendees and an a 80% ratio from...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.
Must read